Browse Data and Analysis
Filter
Search Data and Analysis
- 12 results found
- (-) Switzerland
- (-) Chile
- (-) New Technologies
- Clear all
This year’s report does not contain significant changes from last year’s report. Chile continues allowing the reproduction of seeds under strict control of the Agricultural and Livestock Service (SAG) of the Ministry of Agriculture.
This year’s report does not contain significant changes from last year’s report. Chile continues allowing the reproduction of seeds under strict control of the Agricultural and Livestock Service (SAG) of the Ministry of Agriculture.
This year’s report does not contain significant changes from last year’s report. Chile continues allowing the reproduction of seeds under strict control of the Agricultural and Livestock Service (SAG) of the Ministry of Agriculture.
There is no commercial production of Genetically Engineered (GE) crops in Chile, with the exception of seeds for re-export.
There are no changes in regulations since last year’s report.
While Chile remains the tenth largest producer of seeds in the world and the United States is the largest market for Genetically Engineered (GE) seeds, seed developers and researchers....
Biotech products can be produced in Chile only for reproduction and research purposes.
The third annual Post-organized biotechnology seminar entitled “Biotechnology and Sustainable Agricultural Production” was held June 13, 2017 at the WTO.
Agricultural biotechnology policy has not been a priority of Chile’s current administration. FAS/Santiago expects Chile’s agricultural biotechnology policies to remain unchanged.
FAS Geneva organized a biotechnology seminar entitled “The Impact of Biotechnology on Developing World Agriculture, Nutrition, and the Environment” on September 22, 2015 at the WTO.
Agricultural biotechnology is not a priority for Chile’s current Administration. The situation in Chile remains the same as last year and is expected to remain that way through this Administration.
Although events occurred over the past year that looked like Chile might move on its biotechnology framework, in the end, Chile is in the same place as it was last year.